Patients affected by pseudohypoparathyroidism (PHP) or related disorders are characterized by physical findings that may include brachydactyly, a short stature, a stocky build, early-onset obesity, ectopic ossifications, and neurodevelopmental deficits, as well as hormonal resistance most prominently to parathyroid hormone (PTH). In addition to these alterations, patients may develop other hormonal resistances, leading to overt or subclinical hypothyroidism, hypogonadism and growth hormone (GH) deficiency, impaired growth without measurable evidence for hormonal abnormalities, type 2 diabetes, and skeletal issues with potentially severe limitation of mobility. PHP and related disorders are primarily clinical diagnoses. Given the variability of the clinical, radiological, and biochemical presentation, establishment of the molecular diagnosis is of critical importance for patients. It facilitates management, including prevention of complications, screening and treatment of endocrine deficits, supportive measures, and appropriate genetic counselling. Based on the first international consensus statement for these disorders, this article provides an updated and ready-to-use tool to help physicians and patients outlining relevant interventions and their timing. A life-long coordinated and multidisciplinary approach is recommended, starting as far as possible in early infancy and continuing throughout adulthood with an appropriate and timely transition from pediatric to adult care.

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients / G. Mantovani, M. Bastepe, D. Monk, L. de , Sanctis, S. Thiele, S.  , F. Ahmed, R. Bufo, T. Choplin, G. De , Filippo, G. Devernois, T. Eggermann, Francesca , M. Elli, A. Garcia , R. Emily , L. Germain-Lee, L. Groussin, Neveen , A.T. Hamdy, P. Hanna, O. Hiort, H. Jüppner, P. Kamenický, N. Knight, E. Le , Norcy, B. Lecumberri, Michael , A. Levine, O. Mäkitie, R. Martin, Gabriel , Á. Martos-Moreno, M. Minagawa, P. Murray, A. Pereda, R. Pignolo, L. Rejnmark, R. Rodado, A. Rothenbuhler, V. Saraff, Ashley , H. Shoemaker, Eileen , M. Shore, C. Silve, S. Turan, P. Woods, M.  , C. Zillikens, G. Perez , D. Nanclares, A. Linglart. - In: HORMONE RESEARCH IN PAEDIATRICS. - ISSN 1663-2818. - 93(2020 Sep), pp. 182-196. [10.1159/000508985]

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients

G. Mantovani
Primo
;
M. Elli;
2020

Abstract

Patients affected by pseudohypoparathyroidism (PHP) or related disorders are characterized by physical findings that may include brachydactyly, a short stature, a stocky build, early-onset obesity, ectopic ossifications, and neurodevelopmental deficits, as well as hormonal resistance most prominently to parathyroid hormone (PTH). In addition to these alterations, patients may develop other hormonal resistances, leading to overt or subclinical hypothyroidism, hypogonadism and growth hormone (GH) deficiency, impaired growth without measurable evidence for hormonal abnormalities, type 2 diabetes, and skeletal issues with potentially severe limitation of mobility. PHP and related disorders are primarily clinical diagnoses. Given the variability of the clinical, radiological, and biochemical presentation, establishment of the molecular diagnosis is of critical importance for patients. It facilitates management, including prevention of complications, screening and treatment of endocrine deficits, supportive measures, and appropriate genetic counselling. Based on the first international consensus statement for these disorders, this article provides an updated and ready-to-use tool to help physicians and patients outlining relevant interventions and their timing. A life-long coordinated and multidisciplinary approach is recommended, starting as far as possible in early infancy and continuing throughout adulthood with an appropriate and timely transition from pediatric to adult care.
Acrodysostosis; Bone disorders; Brachydactyly; Calcium and phosphate metabolism; Consensus; Diagnosis; Management; Ossification; Parathyroid hormone; Pseudohypoparathyroidism; Treatment
Settore MED/13 - Endocrinologia
set-2020
5-ago-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Brief consensus Hormone Res in Paediatrics.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 560.14 kB
Formato Adobe PDF
560.14 kB Adobe PDF Visualizza/Apri
document.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 576.32 kB
Formato Adobe PDF
576.32 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/758373
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 39
social impact